 |
|
| |
|
17-18 January 2007, London |
|
|
Agenda
Day One - 17 January
|
09:30 |
Registration
|
|
10:30 |
Technology Trends
|
|
10:35 |
Nanoparticles for Molecular Imaging and Targeted Therapy: Science and Fiction
Ulrich Pison, Professor, Charité, Berlin University of Medicine and Editor in chief, the Nanotechnology, Diagnostics, and Therapeutics Journal |
|
11:10 |
Coffee break and networking in exhibition hall
|
|
11:55 |
Proteomic Strategies in Biomarker Discovery
Julio Celis, Scientific Director, Institute of Cancer Biology and Danish Cancer Society, Danish Centre for Translational Research in Breast Cancer
|
|
12:30 |
The Role of Biomedical Imaging in the Drug Discovery Process
Leonard Fass, Director Academic Relations, GE Healthcare
|
|
13:05 |
Lunch arranged by the Savoy Hotel
|
|
14:15 |
“Technology Trends” cont. |
|
14:20 |
Clinical Applications of Human Stem Cells - Prospects and Challenges
Stephen Minger, Director, Stem Cell Biology Laboratory, Wolfson Centre for Age Related Diseases, King's College London
|
|
14:55 |
High-Throughput RNAi and Pathway-Centred Drug Discovery
Michael Boutros, Head, Signalling and Functional Genomics, DKFZ
|
|
15:30 |
Coffee/Tea Break and networking in the exhibition
|
|
16:15 |
ClonePix FL- Powerful Technology for Screening and Isolating High Value Mammalian Cells
Julian Burke, Chief Scientific Officer, Genetix Group Plc.
|
|
16:50 |
Cell Based Assays in Primary Screening & Lead Optimisation
Andreas Sewing, Associate Director, Primary Pharmacology Group, Pfizer
|
|
17:25 |
End of session |
|
17:30 |
Cocktail Reception |
|
19:00 |
Gala Dinner at the Savoy Hotel |
Back to top
Day Two - 18 January
|
10:00 |
“Technology Trends” cont. |
|
10:05 |
Automatic 2D Depiction of Molecules
Wolfram Altenhofem, Director of Scientific Services, Chemical Computing Group AG |
|
10:40 |
A Serum Efficiacy Biomarker for Clinical Trials: Measuring Tumor Cell Apoptosis and Necrosis in Serum during Cancer Therapy
Stig Linder, Professor, Karolinska Institute |
|
11:15 |
Coffee/Tea Break and networking in the exhibition |
|
12:00 |
Outsourcing Trends
|
|
12:05 |
Current Trends & Future Prospects for Outsourcing
Tim Sparey, Director, Scientific Liaison, Merck, Sharp & Dohme
|
|
12:40 |
Bridging the Translational Medicine Gap Between Academia and Industry
Colin Wyatt, Director of Business Development, Imperial College London
|
|
13:15 |
Lunch arranged by the Savoy Hotel
|
|
14:15 |
“Outsourcing Trends” cont. |
|
14:20 |
Outsourcing Discovery Chemistry: Go East
Bill Primrose, Business Development Director, SioKem |
|
14:55 |
The Benefit and Challenge of Outsourcing R&D in China
Xian-Ping Lu, CSO, ChipScreen Biosciences Ltd
|
|
15:30 |
Close of meeting with coffee and tea |
Back to top |
|
|
|